Gamida Restructures Under Ownership of Highbridge Capital Management 3/29/2024

EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer 3/28/2024

Akebia’s CKD Anemia Drug Ends Tough Regulatory Path with FDA Approval 3/28/2024

Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of... 3/28/2024

Stoke Announces $125M Public Offering on Heels of Positive Data for Epilepsy Drug 3/28/2024

Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH 3/28/2024

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy 3/28/2024

Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates 3/28/2024

How to Set and Maintain Boundaries at Work 3/28/2024

Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer 3/27/2024

Opinion: AbbVie-Landos Deal Signals Continued Momentum for Next-Gen I&I Drugs 3/27/2024

Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint 3/27/2024

Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program 3/27/2024

Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment 3/27/2024

Avenzo Closes $150M Oversubscribed Series A-1 to Advance Cancer Therapies 3/27/2024

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData 3/27/2024

Bayer’s Sweeping Executive Cuts, Wegovy’s Expanding Reach 3/27/2024

Global Healthcare Celebrates Tech Successes & Grapples with Cybersecurity at HIMSS 2024 3/27/2024

Analysts Predict Slower Rollout but Ultimate Victory for Casgevy in Race with Lyfgenia 3/27/2024

C-Suite Shuffle: A2 Bio, Bayer, BioNTech and More 3/27/2024